Oxidation and age-related macular degeneration: Insights from molecular biology

Expert Reviews in Molecular Medicine

Volumn 12, Issue , 2010, Pages

  Khandhadia, Sam ^a   Lotery, Andrew ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CRYPTOXANTHIN; CAROTENE; CAROTENOID; CERULOPLASMIN; COPPER; GLUTATHIONE PEROXIDASE; LIPOFUSCIN; LYCOPENE; MELANIN; MELATONIN; MITOCHONDRIAL DNA; N RETINYLIDENE N RETINYLETHANOLAMINE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VASCULOTROPIN; XANTHOPHYLL; ZEAXANTHIN; REACTIVE OXYGEN METABOLITE;

ARMS2 GENE; BLINDNESS; CALORIC RESTRICTION; CELL DAMAGE; CLINICAL FEATURE; COMPLEMENT C3 GENE; COMPLEMENT FACTOR B GENE; COMPLEMENT FACTOR H GENE; DIET SUPPLEMENTATION; DISEASE MARKER; DNA DAMAGE; DNA MODIFICATION; DRUSEN; EYE PROTECTION; GENE; GENETIC ASSOCIATION; HUMAN; LIGHT STRESS; LIPID PEROXIDATION; MOLECULAR BIOLOGY; NANOMEDICINE; NONHUMAN; OXIDATIVE STRESS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIATION EXPOSURE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; RETINOPATHY; REVIEW; SMOKING HABIT; SUN EXPOSURE; BIOLOGICAL MODEL; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION; RETINA MACULA DEGENERATION;

HUMANS; MACULAR DEGENERATION; MODELS, BIOLOGICAL; MOLECULAR BIOLOGY; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 79952112401     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S146239941000164X     Document Type: Review

References (223)

1. Resnikoff, S. et al. (2004) Global data on visual impairment in the year 2002. Bulletin of the World Health Organization 82, 844-851 (Pubitemid 39573742)
2. de Jong, P.T.V.M. (2006) Age-related macular degeneration. New England Journal of Medicine 355, 1474-1485
3. Friedman, D.S. et al. (2004) Prevalence of age-related macular degeneration in the United States. Archives of Ophthalmology 122, 564-572 (Pubitemid 38456293)
4. Brown, D.M. et al. (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. New England Journal of Medicine 355, 1432-1444 (Pubitemid 44511558)
5. Rosenfeld, P.J. et al. (2006) Ranibizumab for neovascular age-related macular degeneration. New England Journal of Medicine 355, 1419-1431 (Pubitemid 44511557)
6. Schmitz-Valckenberg, S. et al. (2010) Combined confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography imaging of reticular drusen associated with age related macular degeneration. Ophthalmology 117, 1169-1176
7. Klein, R. et al. (2008) The epidemiology of retinal reticular drusen. American Journal of Ophthalmology 145, 317-326
8. Knudtson, M.D. et al. (2004) Location of lesions associated with age-related maculopathy over a 10-year period: the Beaver Dam Eye Study. Investigative Ophthalmology and Visual Science 45, 2135-2142 (Pubitemid 38902581)
9. Lotery, A. and Trump, D. (2007) Progress in defining the molecular biology of age related macular degeneration. Human Genetics 122, 219-236 (Pubitemid 47616531)
10. Augood, C.A. et al. (2006) Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Archives of Ophthalmology 124, 529-535
11. Muller, F.L. et al. (2007) Trends in oxidative aging theories. Free Radical Biology and Medicine 43, 477-503 (Pubitemid 47058228)
12. Chance, B., Sies, H. and Boveris, A. (1979) Hydroperoxide metabolism in mammalian organs. Physiological Reviews 59, 527-605 (Pubitemid 9236599)
13. Golden, T.R. and Melov, S. (2001) Mitochondrial DNA mutations, oxidative stress, and aging. Mechanisms of Ageing and Development 122, 1577-1589
14. Hayflick, L. and Moorhead, P.S. (1961) The serial cultivation of human diploid cell strains. Experimental Cell Research 25, 585-621
15. Yuan, H., Kaneko, T. and Matsuo, M. (1995) Relevance of oxidative stress to the limited replicative capacity of culturedhumandiploid cells: the limit of cumulative population doublings increases under low concentrations of oxygen and decreases in response to aminotriazole. Mechanisms of Ageing and Development 81, 159-168
16. Adelfalk, C. et al. (2001) Accelerated telomere shortening in Fanconi anemia fibroblasts-a longitudinal study. FEBS Letters 506, 22-26 (Pubitemid 32925225)
17. Rubio, M.A., Davalos, A.R. and Campisi, J. (2004) Telomere length mediates the effects of telomerase on the cellular response to genotoxic stress. Experimental Cell Research 298, 17-27 (Pubitemid 38887303)
18. Ballinger, S.W. et al. (1999) Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells. Experimental Eye Research 68, 765-772 (Pubitemid 29290796)
19. Cai, J. et al. (2000) Oxidative damage and protection of the RPE. [Review] [138 Refs]. Progress in Retinal and Eye Research 19, 205-221
20. Susin, S.A. et al. (1999) Mitochondrial release of caspase-2 and -9 during the apoptotic process. Journal of Experimental Medicine 189, 381-394
21. Yang, J. et al. (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132 (Pubitemid 27097312)
22. Lundberg, W.O. (1958) Lipids of biologic importance; peroxidation products and inclusion compounds of lipids. American Journal of Clinical Nutrition 6, 601-603
23. Harman, D. (1956) Aging: a theory based on free radical and radiation chemistry. Journal of Gerontology 11, 298-300
24. Organisciak, D.T. et al. (1998) Light history and age-related changes in retinal light damage. Investigative Ophthalmology and Visual Science 39, 1107-1116 (Pubitemid 28247344)
25. Yamashita, H. et al. (1992) Light-induced retinal damage in mice. Hydrogen peroxide production and superoxide dismutase activity in retina. Retina 12, 59-66
26. van Kuijk, F.J. and Buck, P. (1992) Fatty acid composition of the human macula and peripheral retina. Investigative Ophthalmology and Visual Science 33, 3493-3496
27. Roehlecke, C. et al. (2009) The influence of sublethal blue light exposure on human RPE cells. Molecular Vision 15, 1929-1938
28. Miceli, M.V., Liles, M.R. and Newsome, D.A. (1994) Evaluation of oxidative processes in human pigment epithelial cells associated with retinal outer segment phagocytosis. Experimental Cell Research 214, 242-249 (Pubitemid 24302398)
29. Jiang, S. et al. (2005) Oxidant-induced apoptosis in human retinal pigment epithelial cells: dependence on extracellular redox state. Investigative Ophthalmology and Visual Science 46, 1054-1061 (Pubitemid 41321045)
30. Glotin, A.L. et al. (2008) Prematurely senescent ARPE-19 cells display features of age-related macular degeneration. Free Radical Biology and Medicine 44, 1348-1361
31. Yu, A.L. et al. (2009) Subtoxic oxidative stress induces senescence in retinal pigment epithelial cells via TGF-beta release. Investigative Ophthalmology and Visual Science 50, 926-935
32. Sanvicens, N. et al. (2004) Oxidative stress-induced apoptosis in retinal photoreceptor cells is mediated by calpains and caspases and blocked by the oxygen radical scavenger CR-6. Journal of Biological Chemistry 279, 39268-39278 (Pubitemid 39258188)
33. Fuchshofer, R. et al. (2009) Hypoxia/reoxygenation induces CTGF and PAI-1 in cultured human retinal pigment epithelium cells. Experimental Eye Research 88, 889-899
34. Pemp, B. et al. (2010) Effects of antioxidants (AREDS medication) on ocular blood flow and endothelial function in an endotoxin-induced model of oxidative stress in humans. Investigative Ophthalmology and Visual Science 51, 2-6
35. Gottsch, J.D. et al. (1990) Hematogenous photosensitization. A mechanism for the development of age-related macular degeneration. Investigative Ophthalmology and Visual Science 31, 1674-1682 (Pubitemid 20350888)
36. Yang, D. et al. (2009) Association of superoxide anions with retinal pigment epithelial cell apoptosis induced by mononuclear phagocytes. Investigative Ophthalmology and Visual Science 50, 4998-5005
37. Chen, M., Forrester, J.V. and Xu, H. (2007) Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. Experimental Eye Research 84, 635-645 (Pubitemid 46400631)
38. Thurman, J.M. et al. (2009) Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury. Journal of Biological Chemistry 284, 16939-16947
39. Hollyfield, J.G. et al. (2008) Oxidative damage-induced inflammation initiates age-related macular degeneration. Nature Medicine 14, 194-198 (Pubitemid 351214555)
40. Zhang, B. et al. (2009) Anti-inflammatory and antioxidant effects of SERPINA3 K in the retina. Investigative Ophthalmology and Visual Science 50, 3943-3952
41. Kliffen, M. et al. (1997) Increased expression of angiogenic growth factors in age-related maculopathy. British Journal of Ophthalmology 81, 154-162 (Pubitemid 27092496)
42. Kannan, R. et al. (2006) Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells. Molecular Vision 12, 1649-1659 (Pubitemid 46050311)
43. Sari, A. et al. (2009) Effects of intravitreal bevacizumab in repeated doses: an experimental study. Retina 29, 1346-1355
44. Young, A.J. and Lowe, G.M. (2001) Antioxidant and prooxidant properties of carotenoids. Archives of Biochemistry and Biophysics 385, 20-27 (Pubitemid 32988978)
45. Packer, L. (1993) Antioxidant action of carotenoids in vitro and in vivo and protection against oxidation of human low-density lipoproteins. Annal of the New York Academy of Sciences 691, 48-60
46. Lim, B.P. et al. (1992) Antioxidant activity of xanthophylls on peroxyl radical-mediated phospholipid peroxidation. Biochimica et Biophysica Acta 1126, 178-184
47. Chucair, A.J. et al. (2007) Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid. Investigative Ophthalmology and Visual Science 48, 5168-5177 (Pubitemid 351260928)
48. Nakajima, Y. et al. (2009) Zeaxanthin, a retinal carotenoid, protects retinal cells against oxidative stress. Current Eye Research 34, 311-318
49. Lakshminarayana, R. et al. (2008) Possible degradation/biotransformation of lutein in vitro and in vivo: isolation and structural elucidation of lutein metabolites by HPLC and LC-MS (atmospheric pressure chemical ionization). Free Radical Biology and Medicine 45, 982-993
50. Khachik, F., Bernstein, P.S. and Garland, D.L. (1997) Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Investigative Ophthalmology and Visual Science 38, 1802-1811 (Pubitemid 27382346)
51. Behndig, A. et al. (1998) Superoxide dismutase isoenzymes in the human eye. Investigative Ophthalmology and Visual Science 39, 471-475 (Pubitemid 28110677)
52. Liles, M.R., Newsome, D.A. and Oliver, P.D. (1991) Antioxidant enzymes in the aging human retinal pigment epithelium. Archives of Ophthalmology 109, 1285-1288
53. Sreekumar, P.G. et al. (2005) Protection from oxidative stress by methionine sulfoxide reductases in RPE cells. Biochemical and Biophysical Research Communications 334, 245-253 (Pubitemid 40978532)
54. Kutty, R.K. et al. (1995) Induction of heme oxygenase 1 in the retina by intense visible light: suppression by the antioxidant dimethylthiourea. Proceedings of the National Academy of Sciences of the United States of America 92, 1177-1181
55. Melo, P. et al. (2010) Oxidative stress response in the adult rat retina and plasma after repeated administration of methamphetamine. Neurochemistry International 56, 431-436
56. Peters, S. et al. (2006) Melanin protects choroidal blood vessels against light toxicity. Zeitschrift fur Naturforschung Section C Journal of Biosciences 61, 427-433 (Pubitemid 44073436)
57. Liang, F.Q. et al. (2004) Melatonin protects human retinal pigment epithelial (RPE) cells against oxidative stress. Experimental Eye Research 78, 1069-1075
58. Ryan, S.J. (2006) Retina (4th edn), Elsevier/Mosby, Philadelphia, PA, USA
59. Iwasaki, M. and Inomata, H. (1988) Lipofuscin granules in human photoreceptor cells. Investigative Ophthalmology and Visual Science 29, 671-679
60. Ng, K.P. et al. (2008) Retinal pigment epithelium lipofuscin proteomics. Molecular and Cellular Proteomics 7, 1397-1405
61. Nilsson, S.E. et al. (2003) Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage. Documenta Ophthalmologica 106, 13-16 (Pubitemid 36355966)
62. Wassell, J. et al. (1999) The photoreactivity of the retinal age pigment lipofuscin. Journal of Biological Chemistry 274, 23828-23832
63. Ng, K.P. et al. (2008) Retinal pigment epithelium lipofuscin proteomics. Molecular and Cellular Proteomics 7, 1397-1405
64. Schutt, F. et al. (2003) Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium. Investigative Ophthalmology and Visual Science 44, 3663-3668 (Pubitemid 36909809)
65. Shamsi, F.A. and Boulton, M. (2001) Inhibition of RPE lysosomal and antioxidant activity by the age pigment lipofuscin. Investigative Ophthalmology and Visual Science 42, 3041-3046 (Pubitemid 33035307)
66. Sparrow, J.R. et al. (2003) A2E-epoxides damage DNA in retinal pigment epithelial cells. Vitamin E and other antioxidants inhibit A2E-epoxide formation. Journal of Biological Chemistry 278, 18207-18213 (Pubitemid 36799437)
67. Sparrow, J.R., Nakanishi, K. and Parish, C.A. (2000) The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Investigative Ophthalmology and Visual Science 41, 1981-1989 (Pubitemid 30354376)
68. Sparrow, J.R. and Cai, B. (2001) Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. Investigative Ophthalmology and Visual Science 42, 1356-1362 (Pubitemid 32381981)
69. Zhou, J. et al. (2009) Complement activation by bisretinoid constituents of RPE lipofuscin. Investigative Ophthalmology and Visual Science 50, 1392-1399
70. Wang, Z., Dillon, J. and Gaillard, E.R. (2006) Antioxidant properties of melanin in retinal pigment epithelial cells. Photochemistry and Photobiology 82, 474-479
71. Castorina, C. et al. (1992) Lipid peroxidation and antioxidant enzymatic systems in rat retina as a function of age. Neurochemical Research 17, 599-604
72. Zareba, M. et al. (2006) Effects of photodegradation on the physical and antioxidant properties of melanosomes isolated from retinal pigment epithelium. Photochemistry and Photobiology 82, 1024-1029 (Pubitemid 44450187)
73. Rozanowski, B. et al. (2008) The phototoxicity of aged human retinal melanosomes. Photochemistry and Photobiology 84, 650-657 (Pubitemid 351589361)
74. Feigl, B., Stewart, I. and Brown, B. (2007) Experimental hypoxia in human eyes: implications for ischaemic disease. Clinical Neurophysiology 118, 887-895 (Pubitemid 46349833)
75. Nork, T.M. et al. (2006) Measurement of regional choroidal blood flow in rabbits and monkeys using fluorescent microspheres. Archives of Ophthalmology 124, 860-868 (Pubitemid 43877680)
76. Wing, G.L., Blanchard, G.C. and Weiter, J.J. (1978) The topography and age relationship of lipofuscin concentration in the retinal pigment epithelium. Investigative Ophthalmology and Visual Science 17, 601-607 (Pubitemid 8364255)
77. Bone, R.A. et al. (1997) Distribution of lutein and zeaxanthin stereoisomers in the human retina. Experimental Eye Research 64, 211-218 (Pubitemid 27139567)
78. Rapp, L.M., Maple, S.S. and Choi, J.H. (2000) Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Investigative Ophthalmology and Visual Science 41, 1200-1209 (Pubitemid 30187561)
79. Bertram, K.M. et al. (2009) Molecular regulation of cigarette smoke induced-oxidative stress in human retinal pigment epithelial cells: implications for age-related macular degeneration. American Journal of Physiology - Cell Physiology 297, C1200-C1210
80. Jia, L. et al. (2007) Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by (R)-alpha-lipoic acid. Investigative Ophthalmology and Visual Science 48, 339-348 (Pubitemid 47251422)
81. Kalariya, N.M. et al. (2009) Cadmium-induced apoptotic death ofhuman retinal pigment epithelial cells is mediated by MAPK pathway. Experimental Eye Research 89, 494-502
82. Klein, R. et al. (1993) The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. American Journal of Epidemiology 137, 190-200 (Pubitemid 23083671)
83. Smith, W., Mitchell, P. and Leeder, S.R. (1996) Smoking and age-related maculopathy. The Blue Mountains Eye Study. Archives of Ophthalmology 114, 1518-1523 (Pubitemid 26406270)
84. Vingerling, J.R. et al. (1996) Age-related macular degeneration and smoking. The Rotterdam Study. Archives of Ophthalmology 114, 1193-1196 (Pubitemid 26338849)
85. Tomany, S.C. et al. (2004) Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Archives of Ophthalmology 122, 750-757 (Pubitemid 38596256)
86. West, S.K. et al. (1989) Exposure to sunlight and other risk factors for age-related macular degeneration. Archives of Ophthalmology 107, 875-879 (Pubitemid 19166363)
87. Taylor, H.R. et al. (1990)Visible light and risk of age-related macular degeneration. Transactions of the American Ophthalmological Society 88, 163-173
88. Cruickshanks, K.J., Klein, R. and Klein, B.E. (1993) Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Archives of Ophthalmology 111, 514-518 (Pubitemid 23116899)
89. Darzins, P., Mitchell, P. and Heller, R.F. (1997) Sun exposure and age-related macular degeneration. An Australian case-control study. Ophthalmology 104, 770-776 (Pubitemid 27200873)
90. Fletcher, A.E. et al. (2008) Sunlight exposure, antioxidants, and age-related macular degeneration. Archives of Ophthalmology 126, 1396-1403
91. Bruban, J. et al. (2009) Amyloid-beta(1-42) alters structure and function of retinal pigmented epithelial cells. Aging Cell 8, 162-177
92. Crabb, J.W. et al. (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America 99, 14682-14687 (Pubitemid 35334544)
93. Frank, R.N., Amin, R.H. and Puklin, J.E. (1999) Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neovascular age-related macular degeneration. American Journal of Ophthalmology 127, 694-709 (Pubitemid 29266746)
94. Decanini, A. et al. (2007) Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration. American Journal of Ophthalmology 143, 607-615
95. Totan, Y. et al. (2009) Oxidative macromolecular damage in age-related macular degeneration. Current Eye Research 34, 1089-1093
96. Evereklioglu, C. et al. (2003) Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration. Documenta Ophthalmologica 106, 129-136 (Pubitemid 36355954)
97. Totan, Y. et al. (2001) Plasma malondialdehyde and nitric oxide levels in age related macular degeneration. British Journal of Ophthalmology 85, 1426-1428 (Pubitemid 34032906)
98. Tsai, D.C. et al. (2006) Different plasma levels of vascular endothelial growth factor and nitric oxide between patients with choroidal and retinal neovascularization. Ophthalmologica 220, 246-251
99. Rochtchina, E. et al. (2007) Elevated serum homocysteine, low serum vitamin B12, folate, and age-related macular degeneration: the Blue Mountains Eye Study. American Journal of Ophthalmology 143, 344-346 (Pubitemid 46136142)
100. Seddon, J.M. et al. (2006) Evaluation of plasma homocysteine and risk of age-related macular degeneration. American Journal of Ophthalmology 141, 201-203 (Pubitemid 43016200)
101. Coral, K. et al. (2006) Plasma homocysteine and total thiol content in patients with exudative age-related macular degeneration. Eye (London) 20, 203-207
102. Ates, O. et al. (2009) Decreased serum paraoxonase 1 activity and increased serum homocysteine and malondialdehyde levels in age-related macular degeneration. Tohoku Journal of Experimental Medicine 217, 17-22
103. Nowak, M. et al. (2005) Homocysteine, vitamin B12, and folic acid in age-related macular degeneration. European Journal of Ophthalmology 15, 764-767 (Pubitemid 43074704)
104. Vine, A.K. et al. (2005) Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology 112, 2076-2080 (Pubitemid 41720983)
105. Kamburoglu, G. et al. (2006) Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration. Graefes Archive for Clinical and Experimental Ophthalmology 244, 565-569
106. Axer-Siegel, R. et al. (2004) Association of neovascular age-related macular degeneration and hyperhomocysteinemia. American Journal of Ophthalmology 137, 84-89 (Pubitemid 38045191)
107. Heuberger, R.A. et al. (2002) Relation of blood homocysteine and its nutritional determinants to age-related maculopathy in the third National Health and Nutrition Examination Survey. American Journal of Clinical Nutrition 76, 897-902
108. Wu, K.H. et al. (2007) Circulating inflammatory markers and hemostatic factors in age-related maculopathy: a population-based case-control study. Investigative Ophthalmology and Visual Science 48, 1983-1988 (Pubitemid 351261264)
109. Eye Disease Case-Control Study Group. (1993) Antioxidant status and neovascular age-related macular degeneration. Archives of Ophthalmology 111, 104-109
110. Michikawa, T. et al. (2009) Serum antioxidants and age-related macular degeneration among older Japanese. Asia Pacific Journal of Clinical Nutrition 18, 1-7
111. Mares-Perlman, J.A. et al. (1995) Serum antioxidants and age-related macular degeneration in a population-based case-control study. Archives of Ophthalmology 113, 1518-1523
112. Cardinault, N. et al. (2005) Lycopene but not lutein nor zeaxanthin decreases in serum and lipoproteins in age-related macular degeneration patients. Clinica Chimica Acta 357, 34-42 (Pubitemid 40814432)
113. Simonelli, F. et al. (2002) Serum oxidative and antioxidant parameters in a group of Italian patients with age-related maculopathy. Clinica Chimica Acta 320, 111-115 (Pubitemid 34450829)
114. Prashar, S. et al. (1993) Antioxidant enzymes in RBCs as a biological index of age related macular degeneration. Acta Ophthalmologica 71, 214-218 (Pubitemid 23172674)
115. Yildirim, O. et al. (2004) Changes in antioxidant enzyme activity and malondialdehyde level in patients with age-related macular degeneration. Ophthalmologica 218, 202-206 (Pubitemid 38596587)
116. Cohen, S.M. et al. (1994) Low glutathione reductase and peroxidase activity in age-related macular degeneration. British Journal of Ophthalmology 78, 791-794 (Pubitemid 24311519)
117. Baskol, G. et al. (2006) Serum paraoxonase 1 activity and lipid peroxidation levels in patients with age-related macular degeneration. Ophthalmologica 220, 12-16 (Pubitemid 41832689)
118. De, La Paz, M.A., Zhang, J. and Fridovich, I. (1996) Red blood cell antioxidant enzymes in age-related macular degeneration. British Journal of Ophthalmology 80, 445-450
119. Delcourt, C. et al. (1999) Associations of antioxidant enzymes with cataract and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees a l'Age. Ophthalmology 106, 215-222 (Pubitemid 30191615)
120. Newsome, D.A. et al. (1986) Macular degeneration and elevated serum ceruloplasmin. Investigative Ophthalmology and Visual Science 27, 1675-1680 (Pubitemid 17207838)
121. Schmid-Kubista, K.E. et al. (2009) Daytime levels of melatonin in patients with age-related macular degeneration. Acta Ophthalmologica 87, 89-93
122. Suzuki, M. et al. (2007) Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Molecular Vision 13, 772-778 (Pubitemid 46850583)
123. Choudhary, S. et al. (2005) Toxicity and detoxification of lipid-derived aldehydes in cultured retinal pigmented epithelial cells. Toxicology and Applied Pharmacology 204, 122-134 (Pubitemid 40432370)
124. Fliesler, S.J. and Anderson, R.E. (1983) Chemistry and metabolism of lipids in the vertebrate retina. Progress in Lipid Research 22, 79-131
125. Gu, X. et al. (2003) Oxidatively truncated docosahexaenoate phospholipids: total synthesis, generation, and peptide adduction chemistry. Journal of Organic Chemistry 68, 3749-3761 (Pubitemid 36576624)
126. Gu, X. et al. (2003) Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. Journal of Biological Chemistry 278, 42027-42035 (Pubitemid 37310467)
127. Ebrahem, Q. et al. (2006) Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: implications for age-related macular degeneration.[Erratum appears in Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15722]. Proceedings of the National Academy of Sciences of the United States of America 103, 13480-13484 (Pubitemid 44380133)
128. Gu, J. et al. (2009) Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. Molecular and Cellular Proteomics 8, 1338-1349
129. Ikeda, T. et al. (2001) Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration. American Journal of Ophthalmology 132, 191-195 (Pubitemid 32706513)
130. Javadzadeh, A. et al. (2007) Enhanced susceptibility of low-density lipoprotein to oxidation in wet type age-related macular degeneration in male patients. Saudi Medical Journal 28, 221-224 (Pubitemid 46563796)
131. Ethen, C.M. et al. (2007) Age-related macular degeneration and retinal protein modification by 4-hydroxy-2-nonenal. Investigative Ophthalmology and Visual Science 48, 3469-3479 (Pubitemid 351261080)
132. Johnson, F. and Giulivi, C. (2005) Superoxide dismutases and their impact upon human health. Molecular Aspects of Medicine 26, 340-352 (Pubitemid 41225357)
133. Online Mendelian Inheritance in Man, OMIM (TM). McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD). World Wide Web URL:http://www.ncbi.nlm.nih.gov/omim/
134. Kimura, K. et al. (2000) Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. American Journal of Ophthalmology 130, 769-773 (Pubitemid 32000858)
135. Gotoh, N. et al. (2008) Manganese superoxide dismutase gene (SOD2) polymorphism and exudative age-related macular degeneration in the Japanese population. American Journal of Ophthalmology 146, 146-147
136. Kondo, N. et al. (2009) SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Molecular Vision 15, 1819-1826
137. Esfandiary, H. et al. (2005) Association study of detoxification genes in age related macular degeneration. British Journal of Ophthalmology 89, 470-474 (Pubitemid 40469968)
138. Dong, A. et al. (2009) Oxidative stress promotes ocular neovascularization. Journal of Cellular Physiology 219, 544-552
139. Imamura, Y. et al. (2006) Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America 103, 11282-11287 (Pubitemid 44156510)
140. Hashizume, K. et al. (2008) Retinal dysfunction and progressive retinal cell death in SOD1-deficient mice. American Journal of Pathology 172, 1325-1331 (Pubitemid 351671545)
141. Kasahara, E. et al. (2005) SOD2 protects against oxidation-induced apoptosis in mouse retinal pigment epithelium: implications for age-related macular degeneration. Investigative Ophthalmology and Visual Science 46, 3426-3434 (Pubitemid 44264334)
142. Lu, L. et al. (2009) Increased expression of glutathione peroxidase 4 strongly protects retina from oxidative damage. Antioxidants and Redox Signaling 11, 715-724
143. Jakobsdottir, J. et al. (2005) Susceptibility genes for age-related maculopathy on chromosome 10q26. American Journal of Human Genetics 77, 389-407 (Pubitemid 41192646)
144. Rivera, A. et al. (2005) Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Human Molecular Genetics 14, 3227-3236 (Pubitemid 41631297)
145. Fritsche, L.G. et al. (2008) Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nature Genetics 40, 892-896 (Pubitemid 351913654)
146. Wang, G. et al. (2009) Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria. Investigative Ophthalmology and Visual Science 50, 3084-3090
147. Schmidt, S. et al. (2006) Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. American Journal of Human Genetics 78, 852-864
148. Jones, M.M. et al. (2007) Mitochondrial DNA haplogroups and age-related maculopathy. Archives of Ophthalmology 125, 1235-1240 (Pubitemid 47403031)
149. SanGiovanni, J.P. et al. (2009) Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration. PLoS One 4, e5508
150. Swaroop, A. et al. (2009) Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annual Review of Genomics and Human Genetics 10, 19-43
151. Klein, R.J. et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308, 385-389 (Pubitemid 40530070)
152. Haines, J.L. et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308, 419-421 (Pubitemid 40530081)
153. Edwards, A.O. et al. (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308, 421-424 (Pubitemid 40530082)
154. Yates, J.R. et al. (2007) Complement C3 variant and the risk of age-related macular degeneration. New England Journal of Medicine 357, 553-561 (Pubitemid 47236280)
155. Gold, B. et al. (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nature Genetics 38, 458-462
156. Ennis, S. et al. (2009) Support for the involvement of complement factor I in age-related macular degeneration. European Journal of Human Genetics 18, 15-16
157. Fagerness, J.A. et al. (2009) Variation near complement factor I is associated with risk of advanced AMD. European Journal of Human Genetics 17, 100-104
158. Hageman, G.S. et al. (2006) Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Annals of Medicine 38, 592-604 (Pubitemid 46292019)
159. Hughes, A.E. et al. (2006) A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nature Genetics 38, 1173-1177 (Pubitemid 44470363)
160. Ennis, S. et al. (2008) Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study. Lancet 372, 1828-1834
161. Meyers, S.M., Ostrovsky, M.A. and Bonner, R.F. (1993) A model of spectral filtering to reduce photochemical damage in age-related macular degeneration. Transactions of the American Ophthalmological Society 102, 83-93
162. Khan, J.C. et al. (2006) Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. British Journal of Ophthalmology 90, 75-80 (Pubitemid 43029901)
163. Sundelin, S.P. and Nilsson, S.E. (2001) Lipofuscinformation in retinal pigment epithelial cells is reduced by antioxidants. Free Radical Biology and Medicine 31, 217-225 (Pubitemid 32607588)
164. Chong, E.W. et al. (2007) Dietary antioxidants and primary prevention of age related macular degeneration: systematic reviewand meta-analysis. BMJ 335, 755-758
165. Age-Related Eye Disease Study Research Group. (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 [Erratum appears in Arch Ophthalmol. 2008 Sep;126(9):1251]. Archives of Ophthalmology 119, 1417-1436
166. Vanderbilt University, USA. Antioxidant systems and age-related macular degeneration. In ClinicalTrials.gov [Internet], National Library of Medicine (US), Bethesda, MD, USA, 2000 [cited 2010 July 07], available from: http://clinicaltrials.gov/ct2/show/NCT00668213. NLM Identifier: NCT00668213
167. Omenn, G.S. et al. (1996) Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. Journal of National Cancer Institute 88, 1550-1559 (Pubitemid 26374508)
168. National Eye Institute (NEI). Age-related eye disease study 2 (AREDS2). In ClinicalTrials.gov [Internet], National Library of Medicine (US), Bethesda, MD, USA, 2000 [cited 2010 March 20], available from: http://clinicaltrials.gov/ ct2/show/NCT00345176. NLM Identifier: NCT00345176
169. Centre de Recherche en Nutrition Humaine Rhone-Alpe, France. Superoxide dismutase (SOD) as antioxidant treatment of age related macular degeneration (ARMD). In ClinicalTrials.gov [Internet], National Library of Medicine (US), Bethesda, MD, USA, 2000 [cited 2010 July 07], available from: http://clinicaltrials.gov/ct2/show/NCT00800995. NLM Identifier: NCT00800995
170. Zhang, B. and Osborne, N.N. (2006) Oxidative-induced retinal degeneration is attenuated by epigallocatechin gallate. Brain Research 1124, 176-187 (Pubitemid 44779557)
171. National Eye Institute (NEI), USA. Effects of antioxidants on human macular pigments. In ClinicalTrials.gov [Internet], National Library of Medicine (US), Bethesda, MD, USA, 2000 [cited 2010 July 07], available from http://clinicaltrials.gov/ct2/show/NCT00718653. NLM Identifier: NCT00718653
172. Li, L. et al. (2010) Supplementation with lutein or lutein plus green tea extracts does not change oxidative stress in adequately nourished older adults. Journal of Nutritional Biochemistry 21, 544-549
173. Singh, S. and Aggarwal, B.B. (1995) Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. Journal of Biological Chemistry 270, 24995-25000
174. Scapagnini, G. et al. (2006) Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxidants and Redox Signaling 8, 395-403 (Pubitemid 43741311)
175. Abe, Y., Hashimoto, S. and Horie, T. (1999) Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacological Research 39, 41-47
176. Mandal, M.N. et al. (2009) Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radical Biology and Medicine 46, 672-679
177. Dubey, A.K. et al. (2004) Ginkgo biloba - an appraisal. [Review] [44 Refs]. Kathmandu University Medical Journal 2, 225-229
178. King, R.E., Kent, K.D. and Bomser, J.A. (2005) Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signal-regulated kinase inhibition. Chemico-Biological Interactions 151, 143-149 (Pubitemid 40208564)
179. Kumar, A. and Sharma, S.S. (2010) NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochemical and Biophysical Research Communications 394, 360-365
180. Kook, D. et al. (2008) The protective effect of quercetin against oxidative stress in the human RPE in vitro. Investigative Ophthalmology Visual Science 49, 1712-1720
181. Wielgus, A.R. et al. (2007) Phototoxicity in human retinal pigment epithelial cells promoted by hypericin, a component of St. John's wort. Photochemistry and Photobiology 83, 706-713 (Pubitemid 46854941)
182. Wong, W.T. et al. (2010) Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial. Investigative Ophthalmology Visual Science 2010 Jun 23 [Epub ahead of print]
183. Wan, F. and Lenardo, M.J. (2010) The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives. Cell Research 20, 24-33
184. Dutta, J. et al. (2006) Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene 25, 6800-6816 (Pubitemid 44657853)
185. Hatada, E.N., Krappmann, D. and Scheidereit, C. (2000) NF-kappaB and the innate immune response. Current Opinion in Immunology 12, 52-58
186. Mankan, A.K. et al. (2009) NF-kappaB regulation: the nuclear response. Journal of Cellular and Molecular Medicine 13, 631-643
187. Nordberg, J. and Arner, E.S. (2001) Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radical Biology and Medicine 31, 1287-1312 (Pubitemid 33145299)
188. Berndt, C., Lillig, C.H. and Holmgren, A. (2007) Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. AJP - Heart and Circulatory Physiology 292, H1227-H1236
189. Wang, X.W. et al. (2008) Thioredoxin-like 6 protects retinal cell line from photooxidative damage by upregulating NF-kappaB activity. Free Radical Biology and Medicine 45, 336-344
190. Tanito, M. et al. (2002) Cytoprotective effect of thioredoxin against retinal photic injury in mice. Investigative Ophthalmology and Visual Science 43, 1162-1167 (Pubitemid 34258288)
191. Arnér, E.S.J. and Holmgren, A. (2006) The thioredoxin system in cancer. Seminars in Cancer Biology 16, 420-426 (Pubitemid 44780139)
192. Migliaccio, E. et al. (1999) The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402, 309-313
193. Wu, Z. et al. (2006) Reduction of p66Shc suppresses oxidative damage in retinal pigmented epithelial cells and retina. Journal of Cellular Physiology 209, 996-1005 (Pubitemid 44665722)
194. Capitani, N. et al. (2010) Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia. Blood 115, 3726-3736
195. Li, Q. et al. (2008) Downregulation of p22phox in retinal pigment epithelial cells inhibits choroidal neovascularization in mice. Molecular Therapy: The Journal of the American Society of Gene Therapy 16, 1688-1694
196. Chen, B. et al. (2009) Delivery of antioxidant enzyme genes to protect against ischemia/reperfusion-induced injury to retinal microvasculature. Investigative Ophthalmology and Visual Science 50, 5587-5595
197. Rex, T.S. et al. (2004) Adenovirus-mediated delivery of catalase to retinal pigment epithelial cells protects neighboring photoreceptors from photo-oxidative stress. Human Gene Therapy 15, 960-967 (Pubitemid 39372572)
198. Gao, X. and Talalay, P. (2004) Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage. Proceedings of the National Academy of Sciences of the United States of America 101, 10446-10451 (Pubitemid 38924945)
199. del, V.C. et al. (2008) Demonstration by redox fluorometry that sulforaphane protects retinal pigment epithelial cells against oxidative stress. Investigative Ophthalmology and Visual Science 49, 2606-2612
200. Liu, X.P. et al. (2007) Extract of Ginkgo biloba induces phase 2 genes through Keap1-Nrf2-ARE signaling pathway. Life Sciences 80, 1586-1591
201. Talalay, P. (2000) Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors 12, 5-11
202. Talalay, P., Dinkova-Kostova, A.T. and Holtzclaw, W.D. (2003) Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Advances in Enzyme Regulation 43, 121-134 (Pubitemid 36872827)
203. Dong, A. et al. (2007) Increased expression of glial cell line-derived neurotrophic factor protects against oxidative damage-induced retinal degeneration. Journal of Neurochemistry 103, 1041-1052 (Pubitemid 47568739)
204. Godley, B.F. et al. (2002) Bcl-2 overexpression increases survival in human retinal pigment epithelial cells exposed to H(2)O(2). Experimental Eye Research 74, 663-669 (Pubitemid 34948367)
205. Chen, J. et al. (2006) Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nature Nanotechnology 1, 142-150
206. Fawcett, R.J. and Osborne, N.N. (2007) Flupirtine attenuates sodium nitroprusside-induced damage to retinal photoreceptors, in situ. Brain Research Bulletin 73, 278-288 (Pubitemid 46880064)
207. Pitha-Rowe, I. et al. (2009) Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3 K/AKT signaling through inhibition of the lipid phosphatase PTEN. Investigative Ophthalmology and Visual Science 50, 5339-5347
208. Petronelli, A., Pannitteri, G. and Testa, U. (2009) Triterpenoids as new promising anticancer drugs. Anticancer Drugs 20, 880-892
209. Onaivi, E.S. (2009) Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications. International Review of Neurobiology 88, 335-369
210. Matias, I. et al. (2006) Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. Prostaglandins, Leukotrienes, and Essential Fatty Acids 75, 413-418 (Pubitemid 44648737)
211. Wei, Y., Wang, X. and Wang, L. (2009) Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells. Molecular Vision 15, 1243-1251
212. Butler, H. and Korbonits, M. (2009) Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists. European Journal of Endocrinology 161, 655-662
213. Lacombe, C. and Mayeux, P. (1998) Biology of erythropoietin. Haematologica 83, 724-732 (Pubitemid 28492155)
214. Katavetin, P. et al. (2007) Antioxidative effects of erythropoietin. Kidney International. Supplement S10-S15 (Pubitemid 47609057)
215. Chung, H. et al. (2009) Neuroprotective role of erythropoietin by antiapoptosis in the retina. Journal of Neuroscience Research 87, 2365-2374
216. Shah, S.S., Tsang, S.H. and Mahajan, V.B. (2009) Erythropoetin receptor expression in the human diabetic retina. BMC Research Notes 2, 234
217. Wang, Z.Y. et al. (2009) Erythropoietin protects retinal pigment epithelial cells from oxidative damage. Free Radical Biology and Medicine 46, 1032-1041
218. Rex, T.S. et al. (2009) Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse. Experimental Eye Research 89, 735-740
219. Yodoi, Y. et al. (2007) Circulating hematopoietic stem cells in patients with neovascular age-related macular degeneration. Investigative Ophthalmology and Visual Science 48, 5464-5472 (Pubitemid 351260846)
220. Mattison, J.A. et al. (2007) Dietary restriction in aging nonhuman primates. Interdiscip Top Gerontol 35, 137-158
221. Li, D., Sun, F. and Wang, K. (2003) Caloric restriction retards age-related changes in rat retina. Biochemical and Biophysical Research Communications 309, 457-463 (Pubitemid 37025912)
222. Gouras, P. et al. (2008) Drusenoid maculopathy in rhesus monkeys (Macaca mulatta): effects of age and gender. Graefes Archive for Clinical and Experimental Ophthalmology 246, 1395-1402
223. Kanda, A., Chen, W., Othman, M. et al. (2007) A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America 104, 16227-16232 (Pubitemid 350099389)